7 S Bundle|SSI|Surgical Site Infection|Surgery|Surgical Infection Prevention|HAIs|Working Toward Zero
  • 7 S Bundle Steps
  • #1 Safe Operating Room
  • # 2 Screening and Decolonization
  • #3 Showers before surgery with Chlorhexidine
  • #4 Surgical Skin Prep
  • #5 Solution - Antiseptic Irrigation
  • #6 Sutures - Antimicrobial Sutures
  • #7 Seal Incision - Topical Incisional Adhesive or Antimicrobial Dressings
  • About Us and Contact Form

Chloroprep 2% CHG/70% Alcohol
http://www.carefusion.com/medical-products/infection-prevention/skin-preparation/

Picture
ChloraPrep patient preoperative skin preparation is a rapid-acting, persistent and broad-spectrum antiseptic for a range of minor and major medical procedures. The 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol formulation acts fast on a broad spectrum of bacteria, and keeps fighting bacteria for at least 48 hours.
Together, the formulation and single use applicator reduce microorganisms on the skin.

The 2% chlorhexidine gluconate and 70% isopropyl alcohol formulation provides rapid-acting and persistent antiseptic activity against a broad spectrum of microorganisms.
ChloraPrep applicators promote gentle friction scrub to help the solution penetrate the first five layers of the stratum corneum, where 80% of microorganisms reside. The patented ChloraPrep applicator promotes aseptic technique and reduces the risk of direct hand-to-patient contact, reducing the risk of cross-contamination.


Duraprep
http://www.3m.com/product/information/DuraPrep-Surgical-Solution.html

Picture
Iodine Povacrylex [0.7% available iodine] and Isopropyl Alcohol, 74%
Designed to be applied in a single, painted coat- 2 log reduction - abdomen at 10 minutes- 3 log reduction - groin at 10 minutes- Both sites maintain counts below baseline out to 6 hours

3M™ DuraPrep™ Surgical Prepping Solution gives you effective antimicrobial
kill in a single, painted coat, along with significantly greater drape adhesion
when compared to ChloraPrep® Antiseptic1. 3M™ DuraPrep™ Surgical Prepping
Solution, is not povidone iodine and is not represented in any clinical study
that references PVP-I. 3M™ DuraPrep™ Surgical Prepping Solution keeps resident
bacterial counts low for at least 48 hours after blood and saline challenge, and at least 12 hours against transient bacteria1,2. Don't let the applicators fool your surgical team.  Approved by the FDA to be applied in a single, painted, coat with no scrubbing

ihi_project_joints-_alcohol_skin_prep.ppt
File Size: 2346 kb
File Type: ppt
Download File

chloroprep_orange_inservice.pdf
File Size: 175 kb
File Type: pdf
Download File

zundert_epidural_chg_better.pdf
File Size: 188 kb
File Type: pdf
Download File

edmiston_et_al_ajic_may_2013_CHG paper.pdf
File Size: 711 kb
File Type: pdf
Download File

Carefusion Prevail Surgical Skin Prep

Picture
Prevail One Step Povidone and Alcohol Skin Prep
Broad-spectrum antimicrobial results

Isopropyl alcohol (72.5% w/w) provides fast-acting activity while povidone iodine (0.83% available iodine) has persistent, long-lasting effects.


Generous volume (40 mL)
Ensures total coverage for procedures such as total hip, knee replacement, cardiovascular, C-section and major abdominal surgeries. Also available in a 10 mL size ideal for angiography, hand and foot, head and neck, biopsy, pediatric and other small-area procedures.

https://www.bd.com/en-us/offerings/capabilities/infection-prevention/skin-preparation/prevail-one-step-iodine-based-preps

Picture

ZURAGARD - new alcohol based antiseptic
www.zurexpharma.com/
ZuraGard, a novel preoperative skin antiseptic, was shown to be effective in reducing bacterial counts on the skin of healthy volunteers in two phase 2 trials, performing comparably to the standard antiseptic ChloraPrep. 
ZuraGard is a 70% isopropyl alcohol–based antiseptic formulation with functional excipients, citrate (ie, citric acid and sodium citrate), and alkyl parahydroxybenzoates (with methylene blue as a colorant). The initial antimicrobial efficacy and safety profile for ZuraGard has been assessed in two phase 2 studies involving 96 evaluable healthy participants.
​The agent expressed immediate and persistent antimicrobial activity for up to 24 hours with no skin irritation or other adverse events. The current manuscript reports the findings from a large phase 3 efficacy study conducted according to the 2018 US Food and Drug Administration (FDA) Final Rule, Safety and Effectiveness for Healthcare Antiseptics criteria to assess the efficacy of a novel skin antiseptic on both abdominal and groin skin sites in >800 healthy human participants.

​

Powered by Create your own unique website with customizable templates.